Cancer Treatments Linked to Aggravated Insomnia
the Cancer Therapy Advisor take:
Insomnia symptoms become intensified by cancer treatments and their side effects, according to a study published online in the journal Cancer.
In a longitudinal study involving 465 patients with breast cancer and 263 patients with prostate cancer, Insomnia Severity Index (ISI) and somatic symptoms were assessed at baseline and 2, 6, 10, 14, and 18 months later.
Results showed that patients with breast cancer who underwent radiotherapy and chemotherapy experienced an increased insomnia severity, but those who underwent hormone therapy did not. In patients with prostate cancer, androgen deprivation therapy was also associated with increased insomnia.
A variety of somatic symptoms were found to significantly mediate the effects of chemotherapy and radiotherapy on insomnia in patients with breast cancer.
Furthermore, night sweats were determined to have a significant mediating role for hormone therapy in patients with breast cancer and patients with prostate cancer.
The study suggests that side effects of cancer treatments be more closely monitored and managed in order to prevent the aggravation of insomnia symptoms in patients.
Insomnia symptoms become intensified by cancer treatments and their side effects.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Vegan Diet and Cancer
- As HPV-Related Cancer Rates Climb, Experts Scrutinize Barriers to HPV Vaccination
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Duvelisib Delayed Progression in CLL/SLL: Study
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Prostate Cancer Drug Treatments
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Lenalidomide Induces Immunity, Produces Clinical Response in CLL
- Comorbidities Signal Worse Outcomes in CLL After Targeted Treatment
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Immune-Related Adverse Events Due to Checkpoint Inhibition Are More Common in Melanoma Than in NSCLC
- Potential Diagnostic Tool Detects BCR-ABL1 mRNA in Chronic Myeloid Leukemia